about
Randomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904.Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case report.Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel futureStevens-johnson syndrome induced by vandetanib.(3R,4S,5R)-Methyl 3,5-bis-[(tert-butyl-dimethyl-sil-yl)-oxy]-4-meth-oxy-cyclo-hex-1-ene-carboxyl-ateEvolving therapies in the treatment of hepatocellular carcinomaEfficacy and tolerability of pharmacotherapy options for the treatment of medullary thyroid cancer.Design, synthesis, and antitumor activities of some novel substituted 1,2,3-benzotriazines.Photosensitivity reactions to vandetanib: redevelopment after sequential treatment with docetaxel.Targeted medical therapy of biliary tract cancer: recent advances and future perspectives.Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: recent advances and future perspectives.Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer.
P2860
Q33903078-EE03D3F2-4956-4B75-B163-9BD5A8393ED6Q35108522-19302059-D183-4A47-B79E-59A435B3A1F7Q35640101-7D67AE25-D145-4100-84F7-311508649DFFQ35748786-30EAAB07-4D37-413B-98C9-98687A2DAAD1Q36826533-AC63458E-3CF9-4251-9E38-380EE3A0EBD5Q37290714-58984855-E5D5-4A39-9D52-8910D43770CDQ38058321-CDDF476A-BF35-46A7-A6E9-2062CB905E55Q39965992-CB320FF2-9AE6-4F7D-9116-4E397EBC0485Q41002305-11F89907-357E-4989-9AA7-F1770BADAC89Q42635172-7D4363DE-A113-4F9C-890D-7461D1F7F3D8Q43097453-9903F0A3-EF06-44D5-8B29-211AEB58604FQ43141124-16E95078-813E-4D9B-963A-4DCF9DDFE8C0
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
ZD6474--clinical experience to date.
@ast
ZD6474--clinical experience to date.
@en
type
label
ZD6474--clinical experience to date.
@ast
ZD6474--clinical experience to date.
@en
prefLabel
ZD6474--clinical experience to date.
@ast
ZD6474--clinical experience to date.
@en
P2860
P356
P1476
ZD6474--clinical experience to date.
@en
P2093
J V Heymach
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602604
P407
P478
92 Suppl 1
P577
2005-06-01T00:00:00Z